low molecular weight heparin
A feasibility study to inform the design of a randomized controlled trial to identify the most clinically and cost effective Anticoagulation Length with low molecular weight heparin In the treatment of Cancer Associated Thrombosis (ALICAT): study protocol for a mixed methods study
... Venous thromboembolism (VTE), comprising of deep vein thrombosis (DVT) and pulmonary embolus (PE), is a common phenomenon which occurs in 1 in 1,000 patients and annually affects 6.5 million people worldwide [1,2]. ...
12
Current role of low molecular weight heparin in the treatment of acute ischemic stroke
... to heparin, sustained hypertension with systolic blood pressure >180mmHg and diastolic blood pressure >120mmHg, neurological illness and ...of low molecular weight heparin ...
6
Update on the clinical use of the low-molecular-weight heparin, parnaparin
... of low molecular weight heparin (LMWH) in obese subjects undergoing bariatric surgery: a prospective randomised study comparing two different doses of parnaparin [abstract ...
13
ALIFE2 study: low molecular weight heparin for women with recurrent miscarriage and inherited thrombophilia study protocol for a randomized controlled trial
... with low-molecular-weight heparin (LMWH) or aspirin alone as compared with placebo would improve the live birth rate among 364 women with unexplained recurrent miscarriage (<20 weeks’ ges- ...
10
Cancer-associated thrombosis, low-molecular- weight heparin, and the patient experience: a qualitative study
... Background: Venous thromboembolism is a common complication of cancer and its treatments. Treatment of cancer-associated thrombosis (CAT) differs from treatment of thrombosis in noncancer patients, requiring a daily ...
9
Role of low molecular weight heparin in treatment of acute pancreatitis
... This is to certify that this dissertation titled “THE ROLE OF LOW MOLECULAR WEIGHT HEPARIN IN TREATMENT OF ACUTE PANCREATITIS ” is the bonafide work of Dr.ARAVIND. M Post Graduate student in ...
156
NOVEL NANOPARTICLES FOR THE ORAL DELIVERY OF LOW MOLECULAR WEIGHT HEPARIN: IN VITRO AND IN VIVO ASSESSMENT
... Low-molecular-weight heparin (LMWH) is used as an anticoagulant in mostly two common post-surgical complications such as deep vein thrombosis and pulmonary ...large molecular size, high ...
8
Low Molecular Weight Heparin as A Therapeutic Tool for Cancer; Special Emphasis on Breast Cancer
... modified heparin they used was sulfated non-anticoagulant heparin (S-NACH) which was devoid of antithrombin (AT) binding and inhibition of systemic AT-dependent coagulation factors such as factor Xa and ...
8
Rates of clinically apparent heparin-induced thrombocytopenia for unfractionated heparin vs. low molecular weight heparin in non-surgical patients are low and similar
... for low- molecular-weight heparin (LMWH) is high in the United States, but low in most European ...ated heparin, the choice in favor of LMWH may be clear in Europe, but much less ...
5
Assessment of the Adminstration of Low Molecular Weight Heparin for Hemodialysis Anticoagulation in Comparison to Standard Unfractionated Heparin
... of Low-molecular-weight heparin (LMWH) for hemodialysis anticoagulation has been proposed as effective and safe for hemodialysis (HD) anticoagulation as standard unfractionated heparin ...
8
Original Article A comparison of indobufen and low-molecular-weight heparin in the prevention of deep vein thrombosis in patients after total hip arthroplasty: a prospective randomized controlled study
... Abstract: Objective: This was a prospective, randomized, controlled study to explore the anti-coagulation effective- ness and drug safety of indobufen in patients with total hip arthroplasty. Methods: Patients with ...
9
Low Molecular Weight Heparin in the Treatment of Venous and Arterial Thromboses in the Premature Infant
... with low molecular weight heparin (LMWH) has poten- tial advantages, including predictable pharmacokinetics, subcutaneous administration, and minimal ...
7
Recurrent Implantation Failure and Low Molecular Weight Heparin
... of low molecular weight heparin in the implantation ...process. Heparin has a role at all stages of implantation to improve pregnancy ...studies. Heparin treatment has been ...
17
Low molecular weight heparin in intraocular infusion in high risk group cataract surgery - minimizes inflammatory reaction and prevents posterior capsular opacification
... of low molecular weight heparin in irrigating solution (40 mg/500ml) is effective in minimizing postoperative inflammatory reactions, related complications and posterior capsular opacification ...
10
Evaluation of a Dose Monitoring Method for Prophylactic Anticoagulant Therapy with Low Molecular Weight Heparin
... to low- molecular-weight heparin are reported to be ...of low-molecular-weight heparin ...receiving low-molecular-weight heparin ...
6
The Efficacy of Low-Molecular Weight Heparin in the Management of Generalized Cutaneous Lichen Planus
... Treatment of recalcitrant lichen planus with low molecular weight heparin Enoxaparin: A case series study among Iraqi patients.. 80 Fariba Iraji, Ali Asilian et al.[r] ...
153
Timing of initiation of low-molecular-weight heparin administration in pregnant women with antiphospholipid syndrome: a randomized clinical trial of efficacy and safety
... SA. Heparin inhibits the binding of beta 2-glycoprotein I to phospholipids and promotes the plasmin-mediated inactivation of this blood ...al. Heparin and aspirin attenuate pla- cental apoptosis in vitro: ...
7
Daily administration of low molecular weight heparin increases Hepatocyte Growth Factor serum levels in gynaecological patients: pharmacokinetic parameters and clinical implications
... of low doses of PTX and CDDP on ovarian cancer cells ...as low as those obtained after nadroparin injection are effective in sensitising ovarian cancer cells to ...all, low-doses CDDP and PTX) could ...
8
Impact of Pharmaceutical Care on Self Administration of Outpatient Low Molecular Weight Heparin Therapy
... The strength of our study is the parallel implementation in community pharmacies, allowing: 1) investigation as to whether the interventions are feasible in daily life and 2) direct comparison of the results under ...
14
A study to assess the effectiveness of cold compression on pain and ecchymosis on patients getting subcutaneous low molecular weight heparin in a selected tertiary care hospital
... Methodology: In present study, the researcher selected a single group experimental design, n=35). Keeping in view the objectives of the study, pain and ecchymo sis of patients getting subcutaneous heparin prior ...
5